Neurocrine Biosciences, Inc. <NBIX.O>: Wells Fargo raises target price to $200 from $175
NBIX•Related News
Regenxbio tumbles on deep-discounted $100 mln equity offering
RGNX•
PayPal has limited standalone options to improve growth, Morgan Stanley says
PYPL•
Truist's quarterly profit rises on strength in investment banking and trading
TFC•
Elevance Health <ELV.N>: Deutsche Bank cuts target price to $492 from $498
ELV•
Nike, Inc. <NKE.N>: Deutsche Bank raises target price to $45 from $43
NKE•